Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
Trevena Market Cap
Trevena has a market cap or net worth of $19.18 thousand as of April 16, 2026. Its market cap has decreased by -99.54% in one year.
Market Cap
19.18K
Enterprise Value
24.12M
Revenue
546.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 19.18K, a decrease of -99.99%. That is a compound annual growth rate of -52.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 19.18K | 66.68% |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMV Inc. | 29.42K |
| Statera Biopharma | 29.03K |
| Hemagen Diagnostics | 24.80K |
| America Great Health | 21.15K |
| Health Sciences Group | 20.51K |
| Entia Biosciences | 20.44K |
| Scopus BioPharma | 16.83K |
| NanoLogix | 16.29K |